Market Activities

AAGL 2024 | MacroLux Medical Showcase with nnovating Women's Health Solutions
2024-11-26
The 53rd Annual Meeting of the American Association of Gynecologic Laparoscopists (AAGL 2024) was held from November 17 to 19 in New Orleans, USA.
MEDICA 2024 | MacroLux Shines at Medica 2024: Innovating the Future of Disposable Endoscopes
2024-11-19
From November 11 to 14, 2024, MacroLux Medical participated in Medica 2024 at the Düsseldorf Exhibition Center in Germany. This event is a significant occasion in the global medical technology field, attracting top medical technology and innovative achievements from around the world.
MacroLux Medical Completes Over 14 million dollars in Series B Financing to Accelerate Global Expansion of Disposable Endoscopes.
2024-10-23
We are very pleased to announce that our company (hereinafter referred to as MacroLux Medical) recently announced the completion of over 14 million dollars in Series B financing. The round was led by Yuanbio Venture Capital, with continued support from existing shareholders Legend Capital and Dalton Venture, and Haoyue Capital acted as the exclusive financial advisor.
MacroLux receives CE-MDR Certificate for Single-Use Digital Endoscopes  (no. 6, 7, 8)
2024-09-06
Congratulations to MacroLux Medical on obtaining CE-MDR certification for their three cutting-edge disposable digital endoscopes: LoopView® Single-Use Digital Flexible Bronchoscope, BubbleView® Single-Use Digital Flexible Cystoscope, and SeleneView® Single-Use Digital Hysteroscope.
WCET 2024 | MacroLux Medical Unveiling Innovative Urological Solutions at the WCET 2024
2024-08-22
From August 12th to 16th, 2024, the 41st World Congress of Endourology and Uro-Technology (WCET) was held in Seoul, South Korea. MacroLux Medical showcased its superior urological products during the event in Seoul.
MacroLux receives FDA clearance for Single-Use Digital Hystroscope in the US (no. 5)
2024-08-19
We are thrilled to announce that our disposable hysteroscope SeleneView® has obtained the 510(k) clearance from the U.S. Food and Drug Administration (FDA), marking a momentous milestone for us.
BAUS 2024 | Igniting Innovation and Advancement in Urology - Unveiling the Future of Medical Excellence
2024-07-11
BAUS2024, organized by the British Association of Urological Surgeons (BAUS), brings together urological experts, scholars, and practitioners from around the world. This conference aims to drive innovation and advancement in the field of urology, providing a platform to exchange the latest research findings, clinical practices, and technological developments.
MacroLux receives FDA clearance for Single-Use Digital Flexible Cystoscope in the US (no. 4)
2024-06-11
MacroLux is proud to introduce urologists to their innovative single-use cystoscope, offering a seamless workflow and potential productivity advantages. The BubbleViewTM Single-Use Digital Flexible Cystoscope received 510(k) clearance from the U.S. Food and Drug Administration on June 10, 2024, and is now ready for launch in North America.
共 23 条